Literature DB >> 28161028

Update on traumatic acute spinal cord injury. Part 1.

R Galeiras Vázquez1, M E Ferreiro Velasco2, M Mourelo Fariña3, A Montoto Marqués4, S Salvador de la Barrera2.   

Abstract

Traumatic spinal cord injury requires a multidisciplinary approach both for specialized treatment of the acute phase and for dealing with the secondary complications. A suspicion or diagnosis of spinal cord injury is the first step for a correct management. A review is made of the prehospital management and characteristics of the acute phase of spinal cord injury. Respiratory monitoring for early selective intubation, proper identification and treatment of neurogenic shock are essential for the prevention of secondary spinal cord injury. The use of corticosteroids is currently not a standard practice in neuroprotective treatment, and hemodynamic monitoring and early surgical decompression constitute the cornerstones of adequate management. Traumatic spinal cord injury usually occurs as part of multiple trauma, and this can make diagnosis difficult. Neurological examination and correct selection of radiological exams prevent delayed diagnosis of spinal cord injuries, and help to establish the prognosis.
Copyright © 2016 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  Lesión medular/diagnóstico; Lesión medular/fisiopatología; Shock/etiology; Shock/etiología; Spinal cord injuries/diagnosis; Spinal cord injuries/physiopathology

Mesh:

Substances:

Year:  2017        PMID: 28161028     DOI: 10.1016/j.medin.2016.11.002

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  8 in total

1.  Protective effects of muscone on traumatic spinal cord injury in rats.

Authors:  Chao Yu; Fei Gui; Qian Huang; Yuanmeng Luo; Zili Zeng; Ruifu Li; Liang Guo
Journal:  Ann Transl Med       Date:  2022-06

Review 2.  The Latest View on the Mechanism of Ferroptosis and Its Research Progress in Spinal Cord Injury.

Authors:  Yixin Chen; Suixin Liu; Jianjun Li; Zhe Li; Jing Quan; Xinzhou Liu; Yinbo Tang; Bin Liu
Journal:  Oxid Med Cell Longev       Date:  2020-08-28       Impact factor: 6.543

3.  Identification of key pathways and RNAs associated with skeletal muscle atrophy after spinal cord injury.

Authors:  Li Wei; Guoying Cai; Lian Jiang; Linhui Gao; Zehui Yang; Wei Zhang
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-12-01       Impact factor: 2.041

4.  Human umbilical cord mesenchymal stem cells contribute to the reconstruction of bladder function after acute spinal cord injury via p38 mitogen-activated protein kinase/nuclear factor-kappa B pathway.

Authors:  Jue Li; Jiliang Huang; Ling Chen; Wei Ren; Wenzhi Cai
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 5.  Silk Fibroin Hydrogels Could Be Therapeutic Biomaterials for Neurological Diseases.

Authors:  Chun Yang; Sunao Li; Xinqi Huang; Xueshi Chen; Haiyan Shan; Xiping Chen; Luyang Tao; Mingyang Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-02       Impact factor: 7.310

Review 6.  A Therapeutic Approach Using the Combined Application of Virtual Reality with Robotics for the Treatment of Patients with Spinal Cord Injury: A Systematic Review.

Authors:  Amaranta De Miguel-Rubio; Lorena Muñoz-Pérez; Alvaro Alba-Rueda; Mariana Arias-Avila; Daiana Priscila Rodrigues-de-Souza
Journal:  Int J Environ Res Public Health       Date:  2022-07-19       Impact factor: 4.614

Review 7.  Emerging Potential Therapeutic Targets of Ferroptosis in Skeletal Diseases.

Authors:  Xin Liu; Tianhao Wang; Wei Wang; Xiaolong Liang; Yating Mu; Yaozeng Xu; Jiaxiang Bai; Dechun Geng
Journal:  Oxid Med Cell Longev       Date:  2022-07-30       Impact factor: 7.310

8.  Congenital exercise ability ameliorates muscle atrophy but not spinal cord recovery in spinal cord injury mouse model.

Authors:  Po-An Tai; Yi-Ju Hsu; Wen-Ching Huang; Chun-Hao Chang; Yi-Hsun Chen; Chi-Chang Huang; Li Wei
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.